Advances in the Treatment of Immune Thrombocytopenia: Strategies for Optimizing Clinical and Patient Outcomes | PTCE Pharmacy Connect
Description
Educational Objectives
- Outline current guideline recommendations and strategies pharmacists can implement for the management of immune thrombocytopenia (ITP)
- Recall the efficacy and safety of emerging agents for the treatment of ITP
Moderator:
Anthony J. Perissinotti, PharmD, BCOP
To claim CE credit for this activity, please visit the link below:
Hematology Clinical Pharmacist Specialist
Clinical Team Leader Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan – Michigan Medicine
Ann Arbor, Michigan
Faculty:
Lisa Charneski, PharmD, BCPS
Assistant Dean for Academic Affairs
Philadelphia College of Pharmacy
Associate Professor of Clinical Pharmacy
Department of Pharmacy Practice Saint Joseph’s University
Philadelphia, Pennsylvania
Anthony J. Perissinotti, PharmD, BCOP has the following relevant financial relationships with commercial interests to disclose:
Consultant: AbbVie, BeiGene, Janssen
Lisa Charneski, PharmD, BCPS, has no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.1 CEU) under the ACPE universal activity number 0290-0000-22-608-H01-P. The activity is available for CE credit through December 19, 2023.
This activity is supported by an educational grant from Rigel Pharmaceuticals, Inc.
United States
